<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                               NIH Public Access <br />                                Author Manuscript <br />                                Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                            Published final edited form as: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             Exp Biol Med (Maywood). 2014 May ; 239(5): 581&#226;&#8364;&#8220;594. doi:10.1177/1535370214522183. <br />  <br />  <br />  <br />                            PI3K/Akt pathway restricts epithelial adhesion Dr+ Escherichia <br />                            coli down-regulating expression Decay Accelerating <br />                            Factor (DAF) <br />                            Manu Banadakoppa1, Pawel Goluszko1, Daniel Liebenthal1, Bogdan J. Nowicki2, Stella <br />                            Nowicki2, Chandra Yallampalli1,* <br />                            1Department      Obstetrics Gynecology, The University Texas Medical Branch, Galveston, <br />                            Texas 77555 <br />                            2Department      Obstetrics Gynecology, The Meharry Medical College, Nashville, Tennessee <br />                            37208 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                            <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />                                  The urogenital microbial infection pregnancy important cause maternal neonatal <br />                                  morbidity mortality. Uropathogenic Escherichia coli strains express Dr fimbriae (Dr+) <br />                                  associated unique gestational virulence utilize cell surface decay accelerating <br />                                  factor (DAF CD55) cellular receptor invading epithelial cells. Previous <br />                                  studies laboratory established nitric oxide reduces rate E. coli invasion by <br />                                  delocalizing DAF protein cell surface lipid rafts down-regulating expression. The <br />                                  phosphoinositide 3-kinase/ protein kinase B (PI3K/Akt) cell signal pathway plays important <br />                                  role host-microbe interaction bacteria including E. coli activate pathway in <br />                                  order establish infection. In present study showed PI3K/Akt pathway negatively <br />                                  regulates expression DAF epithelial cell surface inhibits adhesion Dr+ <br />                                  E. coli epithelial cells. Initially, using human cell lines Ishikawa HeLa differ in <br />                                  constitutive activity PI3K/Akt showed DAF levels associated PI3K/Akt <br />                                  pathway. We showed DAF gene expression up-regulated Dr+ E. coli <br />                                  adhesion increased suppression PI3K/Akt pathway Ishikawa cells using inhibitor <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                  LY-294002, plasmid allowed expression PI3K/Akt regulatory protein PTEN. <br />                                  The down-regulation PTEN protein using PTEN-specific siRNA activated PI3K/Akt <br />                                  pathway, down-regulated DAF decreased adhesion Dr+ E. coli. We conclude that <br />                                  PI3K/Akt pathway regulated DAF expression nitric oxide independent manner. <br />  <br />  <br />                            Keywords <br />                                  DAF; CD55; PI3K/Akt pathway; Escherichia coli; PTEN; Kinase; Ishikawa cells <br />  <br />  <br />                            * <br />                             Corresponding author: Chandra Yallampalli, DVM, PhD, Professor, Department Obstetrics Gynecology, Baylor College of <br />                            Medicine, One Baylor Plaza., Texas Children&#226;&#8364;&#8482;s Feigin Centre, C0450.07, Houston, TX 77030, Phone: (832) 824-4188, Fax: (832) <br />                            825-7946, cyallamp@bcm.edu. <br />                            Statement Author Contributions <br />                            MB, PG CY participated design, interpretation data, MB DL conducted experiments, MB wrote, CY BJN <br />                            reviewed manuscript, BJN SN provided plasmids pBJN406 protocol preparation bacteria adhesion assay. <br />                             Banadakoppa et al.                                                                                            Page 2 <br />  <br />  <br />                               Introduction <br />                                                   The urogenital microbial infection (Urinary tract infection UTI) pregnancy an <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   important cause maternal neonatal morbidity mortality (1&#226;&#8364;&#8220;3). The common <br />                                                   bacteria colonize urinary tract cause UTI uropathogenic Escherichia coli <br />                                                   (4). The uropathogenic E. coli bearing Dr fimbriae (Dr+) associated various <br />                                                   pathologies UTIs young adult women, chronic diarrhea children, chronic <br />                                                   pyelonephritis pregnant women (5&#226;&#8364;&#8220;7). The epithelial cell adhesion invasion Dr+ E. <br />                                                   coli shown facilitated glycosylphosphatidylinositol (GPI) anchored cell <br />                                                   surface proteins host carcinoembryonic antigen (CEA)-related cell adhesion <br />                                                   molecules (CEACAMs CD66e) decay accelerating factor (DAF CD55) (8&#226;&#8364;&#8220;10). Dr <br />                                                   adhesins conserved family gram negative bacterial adhesion proteins are <br />                                                   assembled chaperone-usher pathway (11). The biogenesis Dr adhesins structural <br />                                                   molecular level known (12&#226;&#8364;&#8220;15). However, mechanisms interactions <br />                                                   Dr+ E. coli host cells crucial bacterial pathogenesis less <br />                                                   known. Previous studies laboratory shown nitric oxide (NO) down-regulates <br />                                                   DAF expression dose time dependent manner endometrial epithelial cell <br />                                                   line. The reduced DAF expression level associated reduced vitro invasion Dr+ <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   E. coli suggesting down-regulation DAF expression the <br />                                                   mechanisms NO exhibits protective role Dr+ E. coli infection during <br />                                                   pregnancy (16). <br />  <br />                                                   DAF complement regulatory protein widely expressed surface the <br />                                                   serum exposed cells including epithelial cells. DAF bound plasma membrane by <br />                                                   lipid raft associated GPI anchor (17). Apart complement regulatory role, DAF has <br />                                                   implicated physiological pathophysiological conditions. Expression of <br />                                                   DAF endometrium up-regulated secretory phase implantation, <br />                                                   suggesting role immune tolerance implanting conceptus (18;19). The DAF <br />                                                   deficiency associated various diseases paroxysmal nocturnal <br />                                                   hemoglobinurea, luteal phase defect, malarial anemia, psoriatic lesions apoptotic <br />                                                   neutrophils (20&#226;&#8364;&#8220;24). In contrast, higher levels DAF expression associated with <br />                                                   tumorigenesis, decreased tumor cell lysis metastasis types cancers (25;26). <br />  <br />                                                   DAF expression levels vary tissues different physiological and <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   pathophysiological conditions (27). The DAF gene expression regulated transcription <br />                                                   factors Specificity protein 1 (Sp1) cAMP response element-binding protein <br />                                                   (CREB) (17;28). One major cellular signaling cascades activate these <br />                                                   transcription factors Phosphoinositide 3-kinase (PI3K) pathway (29;30). Therefore, we <br />                                                   hypothesized PI3K pathway role regulation DAF expression as <br />                                                   adhesion Dr+ E. coli cells express DAF. <br />  <br />                                                   The PI3K pathway major signaling cascade downstream growth factor receptor <br />                                                   tyrosine kinases. PI3K catalyzes production lipid second messengers as <br />                                                   phosphatidylinositol-3,4,5-triphosphate (PIP3) cell membrane. These <br />                                                   phosphoinositides activate phosphoinositide dependent kinases (PDK) allows the <br />                                                   membrane recruitment protein kinase B (PKB Akt), serine-threonine kinase is <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                               Page 3 <br />  <br />  <br />                                                   central molecule PI3K signaling pathway. PKB activated PDK <br />                                                   dependent phosphorylation phosphorylation sites, amino acid residue threonine-308 <br />                                                   serine-473 (31). A lipid phosphatase, Tensin Homology Deleted Chromosome Ten <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   (PTEN) regulates activity PI3K/Akt dephosphorylating phosphoinositides (32). In <br />                                                   report, examined role PI3K/Akt pathway regulation DAF expression <br />                                                   cellular adhesion Dr+ E. coli using different human genital tract epithelial cell <br />                                                   line models, endometrial Ishikawa cervical HeLa cells. We chosen cell <br />                                                   lines study expression DAF difference constitutive <br />                                                   activity PI3K/Akt pathway. We PI3K/Akt pathway negatively <br />                                                   regulates DAF expression cellular adhesion Dr+ E. coli. <br />  <br />  <br />                               Materials methods <br />                               Cell culture <br />                                                   Ishikawa cells human endometrial cell line derived well-differentiated <br />                                                   endometrial adenocarcinoma shown mimic endometrial epithelial cells (33). <br />                                                   Ishikawa cells routinely cultured Eagle&#226;&#8364;&#8482;s minimum essential medium (MEM) <br />                                                   containing 2 mM L-glutamine, 100 &#194;&#181;g penicillin-streptomycin/ml, 10 mM HEPES <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   supplemented 10% fetal calf serum 37 &#194;&#176;C humidified 5% CO2 atmosphere. <br />                                                   HeLa cells cultured MEM containing 100 &#194;&#181;g penicillin-streptomycin/ml, 10 <br />                                                   mM HEPES supplemented 10% fetal calf serum 37 &#194;&#176;C humidified 5% CO2 <br />                                                   atmosphere. <br />  <br />                               Antibodies reagents <br />                                                   The DAF antibody (monoclonal antibody, cloneIH4) gift D. M. Lublin, <br />                                                   (Washington University School Medicine, Seattle, WA, USA). The Akt (9272), pAkt- <br />                                                   Thr-308 (9275), pAkt-Ser-473 (9271), PDK1(3062), pPDK1 (3485), PTEN (9552) &#206;&#178;- <br />                                                   actin (4970) purchased Cell Signaling Technology (Danvers, MA, USA). The <br />                                                   secondary anti-mouse antibody raised goat purchased Molecular Probes (Grand <br />                                                   Island, NY, USA) The horseradish-peroxidase conjugated anti-rabbit secondary antibody <br />                                                   raised donkey obtained Santa Cruz Biotechnology (Santa Cruz, CA, USA). The <br />                                                   LY294002 purchased Cayman Chemicals (Ann arbor, MI, USA). The L-N-G- <br />                                                   Nitroarginine methyl ester (L-NAME, N5751) purchased Sigma-Aldrich (St. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Louis, MO, USA). <br />  <br />                               Transient transfections cells <br />                                                   The PTEN plasmid purchased addgene (28298, Cambridge, MA, USA). Ishikawa <br />                                                   cells grown 12-well cell culture plates 24 hours media replaced by <br />                                                   Opti-MEM reduced serum medium (31985070, Invitrogen, Carlsbad, CA, USA). The PTEN <br />                                                   plasmid (7.8 &#194;&#181;l) diluted mixing 92.2 &#194;&#181;l Opti-MEM reduced serum medium <span id='am-2' about='protege:TO' typeof='owl:Thing'>to</span> <br />                                                   final concentration 1 &#194;&#181;g/ml. Similarly 2 &#194;&#181;l lipofectamine 2000 (11668019, <br />                                                   Invitrogen) diluted mixing 98 &#194;&#181;l Opti-MEM reduced serum medium and <br />                                                   incubated room temperature 5 minutes. Diluted PTEN plasmid (50 &#194;&#181;l) mixed <br />                                                   diluted lipofectamine 2000 (50 &#194;&#181;l) incubated room temperature 20 minutes. <br />                                                   100 &#194;&#181;l lipofectamine-PTEN plasmid mixture added cells were <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                              Page 4 <br />  <br />  <br />                                                   incubated 37 &#194;&#176;C 48 hours. For controll cells diluted lipofectamine (100 &#194;&#181;l) <br />                                                   prepared described used. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   The PTEN specific siRNA (signal silence PTENsiRNA I) purchased cell signaling <br />                                                   technology (6251). The HeLa cells grown 12-well cell culture plates 24 hours <br />                                                   media replaced Opti-MEM reduced serum medium. The PTEN siRNA <br />                                                   (11.16 &#194;&#181;l) diluted mixing 88.84 &#194;&#181;l Opti-MEM reduced serum medium get <br />                                                   final concentration 1 &#194;&#181;g/ml. Similarly 4 &#194;&#181;l lipofectamine 2000 diluted mixing <br />                                                   94 &#194;&#181;l Opti-MEM reduced serum medium incubated room temperature 5 <br />                                                   minutes. Diluted PTEN siRNA (50 &#194;&#181;l) mixed diluted lipofectamine 2000 (50 <br />                                                   &#194;&#181;l) incubated room temperature 20 minutes. 100 &#194;&#181;l lipofectamine-PTEN siRNA <br />                                                   mixture added cells incubated 37 &#194;&#176;C 48 hours. For the <br />                                                   controll cells PTEN siRNA replaced scrambled siRNA. After transfection, cells <br />                                                   harvested detergent lysis followed scraping using cell scraper western blot <br />                                                   analysis. <br />  <br />                               Western blotting <br />                                                   Harvested cells lysed ice 30 minutes 200 &#194;&#181;l lysis buffer (9803, Cell <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Signalling Technology) containing 5 &#194;&#181;l Phosphatase inhibitor Coctail1, Phosphatase <br />                                                   Inhibitor Coctail 2 Protease Inhibitor (Sigma-Aldrich) supplemented Pefablock SC <br />                                                   1 mM. Lysates collected centrifugation (14,000g) 4 &#194;&#176;C 10 minutes. Protein <br />                                                   concentrations cell lysates determined Pierce BCA protein assay kit (22660, <br />                                                   Thermo Scientific, Rockford, IL, USA), BSA standards. Proteins seperated by <br />                                                   polyacrylamide gel electrophoresis using NuPAGE 4&#226;&#8364;&#8220;12% Bis-Tris mini gels (Invitrogen) <br />                                                   MOPS SDS running buffer 200V 50 minutes. Electrophoresis carried out <br />                                                   reducing conditions DAF, non-reducing conditions were <br />                                                   employed IH4 antibody used recognizes epitope non-rducing <br />                                                   condition. The protein bands identified Western blotting visualized <br />                                                   blue sensitive autoradiography film using supersignal west pico chemiluminiscence <br />                                                   substrate (32132, Thermo Scientific) according instructions provided the <br />                                                   manufacturer. The films scanned protein band densitometric analysis was <br />                                                   performed using AlphaEase Flurochem 8000 software (Alpha Innotech, Santa Clara, <br />                                                   CA, USA). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               RNA isolation real time quantitative PCR <br />                                                   Total RNA isolated cells using RNeasy mini kit (74104, Qiagen, Valencia, <br />                                                   CA, USA) according procedure recommended manufacturer. RNA extraction <br />                                                   followed DNase I (Qiagen) treatment remove DNA contamination. Total RNA of <br />                                                   1 &#194;&#181;g reverse transcribed complementary DNA using avian myeloblastosis virus <br />                                                   reverse transcriptase (M5101, Promega, Madison, WI, USA) random oligonucleotide <br />                                                   hexamers (N8080127, Invitrogen). Quantitative real time PCR carried using CFX96 <br />                                                   SYBR green master mix (Biorad, Hercules, CA, USA). A comparative cycle of <br />                                                   threshold fluorescence (CT) method used housekeeping gene internal control. <br />  <br />  <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                            Page 5 <br />  <br />  <br />                               Proximity Ligation Assay (PLA) <br />                                                   The PLA PCR based immuno-technique visualization insitu protein <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   expression, protein-protein interactions posttranslational protein modifications. The <br />                                                   insitu expression DAF proein cell surface visualized quantified PLA. <br />                                                   The Duolink II kit used PLA purchased Olink Bioscience (Uppsala, <br />                                                   Sweden). The HeLa Ishikawa cells sparsley grown 16-well lab-Tek chamber slides <br />                                                   (Electron Microscopy Sciences, Hatfield, PA, USA) transiently transfected with <br />                                                   PTEN-specific siRNA PTEN plasmid respectively 24 hours. A scrambled siRNA or <br />                                                   tranfection medium served controls. The cells washed twice phosphate <br />                                                   buffered saline fixed using 4% paraformaldehyde. The PLA performed <br />                                                   according instructions provided duolink II kit manufacturer. <br />  <br />                               Bacterial adhesion cells <br />                                                   For E.coli adhesion study used recombinant strain (the laboratory E. coli K-12 strain <br />                                                   carrying plasmid pBJN406) (34). The Ishikawa HeLa cells grown 8-well lab- <br />                                                   Tek chamber slides (Electron Microscopy Sceinces) transiently transfected PTEN <br />                                                   plasmid PTEN siRNA respectively 24 hours. The media removed cells <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   rinsed phosphate buffered saline (PBS). Then, bacterial suspensions 500 &#194;&#181;l of <br />                                                   PBS, prepared described previously (35;36) adherence assay, added the <br />                                                   monolayers Ishikawa HeLa cells, incubated 37 &#194;&#176;C 3 hours. The cells then <br />                                                   rinsed PBS times, bacteria adhered cells visualized gram <br />                                                   staining. <br />  <br />                               Statistical analysis <br />                                                   GraphPad Prism (version6) software used statistical analysis. Comparisons between <br />                                                   groups t-test. Statistical significance (p &lt; 0.05) groups was <br />                                                   determined Bonferroni&#226;&#8364;&#8482;s multiple comparison method. <br />  <br />  <br />                               Results <br />                               Adhesion E. coli expressing Dr+ adhesin epithelial cells associated with <br />                               constitutive activity PI3K-Akt pathway <br />                                                   The PI3K/Akt pathway constitutively active endometrial epithelial cell line Ishikawa <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   truncated <span id='am-81' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-82' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-83' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-84' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-86' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-90' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-91' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-95' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-102' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-103' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-107' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-108' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-113' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-114' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-117' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-123' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-126' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-130' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-131' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-133' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-137' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-139' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-140' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-145' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-147' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-150' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-157' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span>mutation</span> PTEN gene (37). In cervical epithelial cell line HeLa, <br />                                                   functional PTEN expressed therefore, PI3K/Akt pathway regulated (38). <br />                                                   Therefore, used cell lines evaluate role PI3K/Akt pathway the <br />                                                   expression DAF protein adhesion E. coli express Dr+ adhesin. Initially we <br />                                                   confirmed expression levels PTEN HeLa Ishikawa cells analyzed the <br />                                                   expression levels DAF, PDK1, Akt, phosphor-PDK1 (pPDK1) phospho-Akt [pAkt <br />                                                   (Ser473) pAkt (Thr308)] proteins western blotting. The PTEN expressed in <br />                                                   HeLa cells total PDK1 total Akt expressed Ishikawa and <br />                                                   HeLa cells (Figure 1a). However, Western blotting followed densitometric analysis <br />                                                   revealed pPDK1 levels significantly higher Ishikawa cells compared that <br />                                                   HeLa cells (Figure 1b c). The pAkt (Ser473) pAkt (Thr308) detected only <br />  <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                                 Page 6 <br />  <br />  <br />                                                   Ishikawa cells (Figure 1d). Taken results confirmed PI3K/Akt <br />                                                   pathway regulated HeLa cells constitutively active Ishikawa cells. The western <br />                                                   blot analysis DAF protein levels revealed expression dramatically higher in <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   HeLa cells compared Ishikawa cells suggesting association the <br />                                                   PI3K/Akt pathway expression DAF protein (Figure 1e). This result led to <br />                                                   analyze difference adhesion Dr+ E. coli HeLa Ishikawa cells. When <br />                                                   Dr+ E. coli allowed bind monolayers HeLa Ishikawa cells vitro, we <br />                                                   number bacteria adhered individual HeLa cells significantly higher <br />                                                   compared Ishikawa cells (Figure 1f). These data suggested possible association <br />                                                   PI3K/Akt regulated DAF expression Dr+ E. coli adhesion epithelial cells. <br />  <br />                               Pharmacological inhibitor PI3K/Akt pathway up-regulated expression DAF mRNA <br />                               protein <br />                                                   In order estbliash direct evidence link PI3K/Akt pathway DAF <br />                                                   gene expression, Inhibited PI3K/Akt pathway Ishikawa cells using pharmacological <br />                                                   inhibitor LY294002. The western blot followed densitometric analysis Akt its <br />                                                   phosporylation treating Ishikawa cells LY294002 24 hours revealed level <br />                                                   phosphorylation Ser473 Thr308 reduced siginficantly compared of <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   untreated cells (Figure 2a, b c). Then analysed effect LY294002 the <br />                                                   expression DAF gene Ishikawa cells. As shown Figure 2d, real time quantitative <br />                                                   PCR analysis revealed DAF mRNA expression increased significantly LY294002 <br />                                                   treated cells compared control cells. Further, western blot densitometric <br />                                                   analysis showed increase DAF protein expression LY294002 treatment compared <br />                                                   controll cells (Figure 2e f). These data suggested direct inverse relation between <br />                                                   PI3K/Akt pathway DAF gene expression. <br />  <br />                               Introduction plasmid expressing PTEN Ishikawa cells up-regulated DAF <br />                               expression increased Dr+ E. coli adhesion <br />                                                   To confirm role PI3K/Akt DAF gene expression Dr+ E. coli adhesion, <br />                                                   sought manipulate PI3K/Akt pathway altering expression PTEN in <br />                                                   Ishikawa HeLa cells. Initially introduced mammalian expression plasmid for <br />                                                   PTEN Ishikawa cells. The introduction PTEN plasmid allowed Ishikawa cells <br />                                                   over-express PTEN protein (Figure 3a b). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Overexpression PTEN protein significantly reduced level phosphorylation PDK1 <br />                                                   Akt (Figure 3c, d, e f). To assess negative regulation Akt activity <br />                                                   overexpression PTEN protein effect DAF gene expression, we <br />                                                   performed real time quantitative PCR western blot followed densitometric analysis. <br />                                                   As shown Figure 3g, h i, expression DAF mRNA protein increased <br />                                                   significantly overexpression PTEN protein Ishikawa cells. <br />  <br />                                                   Although qPCR western blot provided information expression levels DAF, <br />                                                   wanted know changes cellular localization DAF protein. The DAF protein is <br />                                                   membrane bound protein anchored cell surface GPI molecule and <br />                                                   available cell surface bacterial ligand bind establishing the <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                             Page 7 <br />  <br />  <br />                                                   infection. Therefore, sought determine up-regulation DAF protein <br />                                                   increased DAF protein levels cell surface performing proximity ligation assay <br />                                                   (PLA). The PLA revealed cell surface expression DAF significantly increased in <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Ishikawa cells transfected PTEN plasmid compared control cells (Figure <br />                                                   3j k). Further, Dr+ E. coli allowed bind Ishikawa cells 3 hours, <br />                                                   adhesion individual Ishikawa cells significantly increased introduction of <br />                                                   PTEN plasmid (Figure 3l m). Overall, theses data indicated introduction a <br />                                                   plasmid vector expression PTEN Ishikawa cells up-regulated DAF expression <br />                                                   increased Dr+ E. coli adhesion. <br />  <br />                               Down-regulation PTEN using siRNA HeLa cells down-regulated DAF expression and <br />                               decreased Dr+ E. coli adhesion <br />                                                   We confirmed inverse association PI3K/Akt pathway DAF <br />                                                   expression using PTEN specific siRNA. When HeLa cells transfected PTEN <br />                                                   specific siRNA, expression PTEN protein reduced significantly (Figure 4a b). <br />                                                   The suppression PTEN expression led increase phosphorylation PDK1 and <br />                                                   Akt (Figure 4c, d, e, f) compared control cells. As shown Figure 4g, h i, <br />                                                   PTEN down-regulation induced decreased expression DAF mRNA protein <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   compared control cells. Further, PLA showed decrease DAF protein levels <br />                                                   cell surface siRNA mediated PTEN suppression HeLa cells (Figure 4j <br />                                                   k). The adhesion Dr+ E. coli HeLa cells decreased significantly the <br />                                                   transfection PTEN-specific siRNA (Figure 4i m). Taken together, results <br />                                                   confirmed PI3K/Akt pathway negatively controls expression DAF cell <br />                                                   surface plays important role adhesion Dr+ E. coli. <br />  <br />                               Effect PI3K/Akt pathway DAF expression mediated NO <br />                                                   Earlier studies laboratory demonstrated NO down-regulates expression of <br />                                                   DAF. Therefore, sought examine negative regulation DAF expression by <br />                                                   PI3K/Akt pathway mediated NO. In order study possible role NO, we <br />                                                   inhibited endogenous synthesis NO PTEN knock-down HeLa cells treating the <br />                                                   cells NOS inhibitor L-N-G-Nitroarginine methyl ester (L-NAME) 24h. The <br />                                                   transfection PTEN specific siRNA reduced expression DAF mRNA HeLa <br />                                                   cells compared control cells revealed real time quantitative PCR. However, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   inhibition NO syntehesis using L-NAME did reverse effect PI3K/Akt activation <br />                                                   (Figure 5a) suggesting NO mediating effect PI3K/Akt DAF <br />                                                   expression. <br />  <br />                                                   Then asked NO trigger PI3K/Akt pathway Ishikawa cells to <br />                                                   down-regulate DAF because, NO activates PI3K/Akt pathway bovine human <br />                                                   endothelial cells (39). Previously observed Ishikawa cells, NO donor <br />                                                   Diethylenetriamine (DETA) NONOate (DTNO) down-regulated expression DAF a <br />                                                   concentration 0.1 mM higher (16). Therefore, order examine effect NO on <br />                                                   PI3K/Akt pathway, treated Ishikawa cells 1 mM DTNO 24 hours. As <br />                                                   shown Figure 5b c, western blot followed densitometric analysis revealed <br />                                                   total PDK1 total Akt protein expressions decreased significantly DTNO <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                               Page 8 <br />  <br />  <br />                                                   treatment. Correspondingly, levels pPDK1 pAkt decreased significantly in <br />                                                   DTNO treated cells compared control cells. Together, data demonstrated that <br />                                                   NO reduced PI3K/Akt signaling down-regulating pathway proteins, PDK1 and <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Akt. <br />  <br />                                                   Inhibition NO synthesis using NOS inhibitor, L-NAME failed reverse effect of <br />                                                   PI3K/Akt activation HeLa cells, prompting accept NO mediating the <br />                                                   effect PI3K/Akt pathway DAF protein expression. Instead, observed down- <br />                                                   regulation PDK1 Akt NO, reduce signaling consequently <br />                                                   ought up-regulate DAF expression. However, previous vitro vivo <br />                                                   experiments showed significant down-regulation DAF NO (16;40). This <br />                                                   contradiction direct effect NO DAF gene expression because, <br />                                                   NO decreased DAF mRNA transcription half-life inhibiting binding of <br />                                                   transcription factor Sp1 5&apos;-untranslated region DAF gene HuR protein 3&apos;-UTR of <br />                                                   DAF mRNA respectively (41). <br />  <br />  <br />                               Discussion <br />                                                   The adherence bacteria mucosal surfaces important step pathogenesis of <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   infections humans animals (42). The pathogenic E. coli strains express their <br />                                                   surfaces adhesins invasins responsible recognition binding of <br />                                                   specific membrane-bound host molecules acting receptors. Among pathogenic E. coli <br />                                                   strains, uropathogenic diarrheagenic E. coli express Dr-family adhesins Afa, <br />                                                   Dr F1845 (43). The major receptors host cells recognized adhesins are <br />                                                   type IV collagen, DAF CEACAMs (43;44). In report, shown PI3K/Akt <br />                                                   pathway negatively regulated expression DAF epithelial cells thus <br />                                                   restricted attachment E. coli expressed Dr adhesin. <br />  <br />                                                   Although, bacterial adhesins bind number receptors host cell, DAF <br />                                                   specific pathogens known cause chronic recurrent infections. The Dr/Afa family of <br />                                                   adhesins includes 13 E. coli adhesins involved human diseases (43). Some of <br />                                                   adhesins exhibit narrow specificity host receptors. Except AfaE-VII and <br />                                                   AfaE-VIII, Afa/Dr adhesins bind DAF (45&#226;&#8364;&#8220;47). However, collagen binding <br />                                                   <span id='am-3' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-4' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-5' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-10' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-13' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-17' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-18' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-19' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-24' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-36' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-38' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-40' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-42' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-44' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-50' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-51' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-52' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-54' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-56' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-60' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-68' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-72' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-74' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-75' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-79' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-80' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span>phenotype</span> unique Dr adhesins subfamily Afa/Dr adhesins <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   designated Afa/Dr-I (Afa/DrCEA) bind CECAM family proteins (48;49). Although <br />                                                   binding Dr adhesin type IV collagen critical development persistent renal <br />                                                   infection, role type IV collagen development intestinal infection clear. The <br />                                                   DAF type IV collagen present apical surface polarized intestinal <br />                                                   epithelial cells E. coli tend colonize (49;50). DAF expressed various parts of <br />                                                   digestive, urogenital, respiratory tracts (49;51). In digestive tract, Helicobacter <br />                                                   pylori, causes chronic gastritis attaches DAF protein gastric epithelial cells <br />                                                   (52;53). Coxsackieviruses Enteroviruses utilize DAF receptor host cell <br />                                                   surface (49;54&#226;&#8364;&#8220;56). Therefore, pathogenicity microbial viral ligands DAF <br />                                                   interactions appear involved development protracted subclinical <br />                                                   bacterial viral diseases. <br />  <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                                     Page 9 <br />  <br />  <br />                                                   Bacterial pathogens manipulate host cell kinase signaling nuclear factor <br />                                                   kappa-light-chain-enhancer activated B cells (NF&#206;&#186;B), mitogen activated protein kinase <br />                                                   (MAPK) PI3K/Akt exploit down-stream effector functions order establish <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   intracellular infection (57). PI3K/Akt pathway essential signaling pathway the <br />                                                   process phagocytosis therefore, allows bacterial pathogens hijack PI3K/Akt <br />                                                   signaling induce uptake host cells process similar to <br />                                                   phagocytosis inhibit phagocytosis immune cells macrophages. Yersinia <br />                                                   species inject phosphatase disrupt focal adhesion complex mediated activation of <br />                                                   PI3K/Akt pathway macrophages inhibit phagocytosis (58). Shigella flexneri <br />                                                   Pseudomonas aeruginosa activate host cell PI3K/Akt pathway induce their <br />                                                   epithelial uptake inducing actin reorganization host cells (58). Adherent E. coli strains <br />                                                   reported manipulate PI3K/Akt pathway order establish infection. <br />                                                   Peifer et al, reported invitro intestinal cell model, clinically isolated strain E. <br />                                                   coli C 1845 expressed F1845 adhesin induced F-actin reorganization PI3K/Akt <br />                                                   dependent manner (59). However, role host cell PI3K/Akt pathway protection <br />                                                   bacterial invasion clear. In report provided evidence show <br />                                                   PI3K/Akt pathway involved restricting attachment Dr+ E. coli to <br />                                                   epithelial cells. PI3K/Akt pathway essential pathogenic E. coli gain entry host <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   cells PI3K/Akt signaling activated ligand-receptor interactions host cells <br />                                                   down-regulates DAF restricts attachment proposed Figure 6. The regulation <br />                                                   PI3K/Akt signaling physiological context complex therefore, studies <br />                                                   required establish overall role PI3K/Akt pathway Dr+ E. coli infection. However, <br />                                                   suggest restriction DAF expression contribute limit level virulence <br />                                                   Dr+ E. coli therefore, direct infection process chronic subclinical <br />                                                   infection contrast acute inflammatory diseases caused pathogenic bacteria <br />                                                   shigella species. <br />  <br />                                                   In summary, present study provides evidence association PI3K/Akt <br />                                                   mediated variations DAF expression levels epithelial cells adhesion of <br />                                                   Dr+ E. coli epithelial cells. The involvement independent host systems, NO and <br />                                                   PI3K/Akt down-regulation DAF context Dr+ E. coli pathogenesis appears <br />                                                   consistent host-pathogen strategy achieve controlled limited infection <br />                                                   level. Restricted DAF expression therefore, lead chronic instead acute infection <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   leading symbiotic host-pathogen status, protecting lethal outcome. <br />  <br />  <br />                               Acknowledgments <br />                                                   This work supported National Institute Health [grant number HL72620, HD57013]. <br />  <br />  <br />                               Reference List <br />                                                   1. Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL. A review premature birth and <br />                                                      subclinical infection. Am J Obstet Gynecol. 1992; 166:1515&#226;&#8364;&#8220;1528. [PubMed: 1595807] <br />                                                   2. Hirsch E, Saotome I, Hirsh D. A model intrauterine infection preterm delivery mice. Am J <br />                                                      Obstet Gynecol. 1995; 172:1598&#226;&#8364;&#8220;1603. [PubMed: 7538729] <br />  <br />  <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                                      Page 10 <br />  <br />  <br />                                                   3. Krohn MA, Hillier SL, Nugent RP, Cotch MF, Carey JC, Gibbs RS, Eschenbach DA. The genital <br />                                                      flora women intraamniotic infection. Vaginal Infection Prematurity Study Group. J <br />                                                      Infect Dis. 1995; 171:1475&#226;&#8364;&#8220;1480. [PubMed: 7769281] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   4. Ronald A. The etiology urinary tract infection: traditional emerging pathogens. Am J Med. <br />                                                      2002; 113(Suppl 1A):14S&#226;&#8364;&#8220;19S. [PubMed: 12113867] <br />                                                   5. Pham T, Kaul A, Hart A, Goluszko P, Moulds J, Nowicki S, Lublin DM, Nowicki BJ. dra-related X <br />                                                      adhesins gestational pyelonephritis-associated Escherichia coli recognize SCR-3 SCR-4 <br />                                                      domains recombinant decay-accelerating factor. Infect Immun. 1995; 63:1663&#226;&#8364;&#8220;1668. [PubMed: <br />                                                      7537246] <br />                                                   6. Giron JA, Jones T, Millan-Velasco F, Castro-Munoz E, Zarate L, Fry J, Frankel G, Moseley SL, <br />                                                      Baudry B, Kaper JB. Diffuse-adhering Escherichia coli (DAEC) putative cause diarrhea in <br />                                                      Mayan children Mexico. J Infect Dis. 1991; 163:507&#226;&#8364;&#8220;513. [PubMed: 1995723] <br />                                                   7. Foxman B, Zhang L, Tallman P, Palin K, Rode C, Bloch C, Gillespie B, Marrs CF. Virulence <br />                                                      characteristics Escherichia coli causing urinary tract infection predict risk second <br />                                                      infection. J Infect Dis. 1995; 172:1536&#226;&#8364;&#8220;1541. [PubMed: 7594713] <br />                                                   8. Selvarangan R, Goluszko P, Popov V, Singhal J, Pham T, Lublin DM, Nowicki S, Nowicki B. Role <br />                                                      decay-accelerating factor domains anchorage internalization Dr-fimbriated Escherichia <br />                                                      coli. Infect Immun. 2000; 68:1391&#226;&#8364;&#8220;1399. [PubMed: 10678952] <br />                                                   9. Nowicki B, Hart A, Coyne KE, Lublin DM, Nowicki S. Short consensus repeat-3 domain of <br />                                                      recombinant decay-accelerating factor recognized Escherichia coli recombinant Dr adhesin in <br />                                                      model cell-cell interaction. J Exp Med. 1993; 178:2115&#226;&#8364;&#8220;2121. [PubMed: 7504058] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   10. Guignot J, Peiffer I, Bernet-Camard MF, Lublin DM, Carnoy C, Moseley SL, Servin AL. <br />                                                        Recruitment CD55 CD66e brush border-associated glycosylphosphatidylinositol-anchored <br />                                                        proteins members Afa/Dr diffusely adhering family Escherichia coli infect the <br />                                                        human polarized intestinal Caco-2/TC7 cells. Infect Immun. 2000; 68:3554&#226;&#8364;&#8220;3563. [PubMed: <br />                                                        10816511] <br />                                                   11. Zav&apos;yalov V, Zavialov A, Zav&apos;yalova G, Korpela T. Adhesive organelles Gram-negative <br />                                                        pathogens assembled classical chaperone/usher machinery: structure function a <br />                                                        clinical standpoint. FEMS Microbiol Rev. 2010; 34:317&#226;&#8364;&#8220;378. [PubMed: 20070375] <br />                                                   12. Anderson KL, Billington J, Pettigrew D, Cota E, Simpson P, Roversi P, Chen HA, Urvil P, du ML, <br />                                                        Barlow PN, Medof ME, Smith RA, Nowicki B, Le BC, Lea SM, Matthews S. An atomic <br />                                                        resolution model assembly, architecture, function Dr adhesins. Mol Cell. 2004; <br />                                                        15:647&#226;&#8364;&#8220;657. [PubMed: 15327779] <br />                                                   13. Cota E, Jones C, Simpson P, Altroff H, Anderson KL, du ML, Guignot J, Servin A, Le BC, <br />                                                        Mardon H, Matthews S. The solution structure invasive tip complex Afa/Dr fibrils. <br />                                                        Mol Microbiol. 2006; 62:356&#226;&#8364;&#8220;366. [PubMed: 16965519] <br />                                                   14. Piatek R, Bruzdziak P, Zalewska-Piatek B, Kur J, Stangret J. Preclusion irreversible destruction <br />                                                        Dr adhesin structures high activation barrier unfolding stage fimbrial DraE <br />                                                        subunit. Biochemistry. 2009; 48:11807&#226;&#8364;&#8220;11816. [PubMed: 19891507] <br />                                                   15. Piatek RJ, Bruzdziak P, Zalewska-Piatek BM, Wojciechowski MA, Namiesnik JM, Kur JW. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                        Analysis unique structural physicochemical properties DraD/AfaD invasin the <br />                                                        context belonging family chaperone/usher type fimbrial subunits. BMC Struct Biol. <br />                                                        2011; 11:25. [PubMed: 21575181] <br />                                                   16. Fang L, Nowicki BJ, Urvil P, Goluszko P, Nowicki S, Young SL, Yallampalli C. Epithelial <br />                                                        invasion Escherichia coli bearing Dr fimbriae controlled nitric oxide-regulated expression <br />                                                        CD55. Infect Immun. 2004; 72:2907&#226;&#8364;&#8220;2914. [PubMed: 15102803] <br />                                                   17. Thomas DJ, Lublin DM. Identification 5&apos;-flanking regions affecting expression human <br />                                                        decay accelerating factor gene role tissue-specific expression. J Immunol. 1993; <br />                                                        150:151&#226;&#8364;&#8220;160. [PubMed: 7678027] <br />                                                   18. Fenichel P, Cervoni F, Donzeau M, Hsi BL. Expression role complement regulatory <br />                                                        proteins human gametes pre-implantation embryos. Contracept Fertil Sex. 1995; 23:576&#226;&#8364;&#8220; <br />                                                        580. [PubMed: 7496432] <br />  <br />  <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                                       Page 11 <br />  <br />  <br />                                                   19. Kaul AK, Kumar D, Nagamani M, Goluszko P, Nowicki S, Nowicki BJ. Rapid cyclic changes in <br />                                                       density accessibility endometrial ligands Escherichia coli Dr fimbriae. Infect Immun. <br />                                                       1996; 64:611&#226;&#8364;&#8220;615. [PubMed: 8550215] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   20. Venneker GT, Asghar SS. CD59: molecule involved antigen presentation as <br />                                                       downregulation membrane attack complex. Exp Clin Immunogenet. 1992; 9:33&#226;&#8364;&#8220;47. [PubMed: <br />                                                       1379443] <br />                                                   21. Parker CJ. Molecular basis paroxysmal nocturnal hemoglobinuria. Stem Cells. 1996; 14:396&#226;&#8364;&#8220; <br />                                                       411. [PubMed: 8843541] <br />                                                   22. Kaul A, Nagamani M, Nowicki B. Decreased expression endometrial decay accelerating factor <br />                                                       (DAF), complement regulatory protein, patients luteal phase defect. Am J Reprod <br />                                                       Immunol. 1995; 34:236&#226;&#8364;&#8220;240. [PubMed: 8579761] <br />                                                   23. Stoute JA. Complement-regulatory proteins severe malaria: little good <br />                                                       thing? Trends Parasitol. 2005; 21:218&#226;&#8364;&#8220;223. [PubMed: 15837610] <br />                                                   24. Jones J, Morgan BP. Apoptosis associated reduced expression complement regulatory <br />                                                       molecules, adhesion molecules receptors polymorphonuclear leucocytes: functional <br />                                                       relevance role inflammation. Immunology. 1995; 86:651&#226;&#8364;&#8220;660. [PubMed: 8567034] <br />                                                   25. Murray KP, Mathure S, Kaul R, Khan S, Carson LF, Twiggs LB, Martens MG, Kaul A. Expression <br />                                                       complement regulatory proteins-CD 35, CD 46, CD 55, CD 59-in benign malignant <br />                                                       endometrial tissue. Gynecol Oncol. 2000; 76:176&#226;&#8364;&#8220;182. [PubMed: 10637067] <br />                                                   26. Niehans GA, Cherwitz DL, Staley NA, Knapp DJ, Dalmasso AP. Human carcinomas variably <br />                                                       express complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                       accelerating factor), CD59 (protectin). Am J Pathol. 1996; 149:129&#226;&#8364;&#8220;142. [PubMed: 8686736] <br />                                                   27. Varsano S, Rashkovsky L, Shapiro H, Ophir D, Mark-Bentankur T. Human lung cancer cell lines <br />                                                       express cell membrane complement inhibitory proteins extremely resistant complement- <br />                                                       mediated lysis; comparison normal human respiratory epithelium vitro, insight <br />                                                       mechanism(s) resistance. Clin Exp Immunol. 1998; 113:173&#226;&#8364;&#8220;182. [PubMed: 9717965] <br />                                                   28. Ewulonu UK, Ravi L, Medof ME. Characterization decay-accelerating factor gene promoter <br />                                                       region. Proc Natl Acad Sci U S A. 1991; 88:4675&#226;&#8364;&#8220;4679. [PubMed: 1711208] <br />                                                   29. Bader AG, Kang S, Zhao L, Vogt PK. Oncogenic PI3K deregulates transcription translation. <br />                                                       Nat Rev Cancer. 2005; 5:921&#226;&#8364;&#8220;929. [PubMed: 16341083] <br />                                                   30. Hayakawa J, Ohmichi M, Tasaka K, Kanda Y, Adachi K, Nishio Y, Hisamoto K, Mabuchi S, <br />                                                       Hinuma S, Murata Y. Regulation PRL promoter Akt cAMP response element <br />                                                       binding protein. Endocrinology. 2002; 143:13&#226;&#8364;&#8220;22. [PubMed: 11751586] <br />                                                   31. Franke TF, Kaplan DR, Cantley LC, Toker A. Direct regulation Akt proto-oncogene product <br />                                                       phosphatidylinositol-3,4-bisphosphate. Science. 1997; 275:665&#226;&#8364;&#8220;668. [PubMed: 9005852] <br />                                                   32. Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates lipid second <br />                                                       messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 1998; 273:13375&#226;&#8364;&#8220;13378. <br />                                                       [PubMed: 9593664] <br />                                                   33. Nishida M, Kasahara K, Kaneko M, Iwasaki H, Hayashi K. Establishment new human <br />                                                       endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen progesterone <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                       receptors. Nippon Sanka Fujinka Gakkai Zasshi. 1985; 37:1103&#226;&#8364;&#8220;1111. [PubMed: 4031568] <br />                                                   34. Nowicki B, Hart A, Coyne KE, Lublin DM, Nowicki S. Short consensus repeat-3 domain of <br />                                                       recombinant decay-accelerating factor recognized Escherichia coli recombinant Dr adhesin <br />                                                       model cell-cell interaction. J Exp Med. 1993; 178:2115&#226;&#8364;&#8220;2121. [PubMed: 7504058] <br />                                                   35. Goluszko P, Popov V, Selvarangan R, Nowicki S, Pham T, Nowicki BJ. Dr fimbriae operon of <br />                                                       uropathogenic Escherichia coli mediate microtubule-dependent invasion HeLa epithelial cell <br />                                                       line. J Infect Dis. 1997; 176:158&#226;&#8364;&#8220;167. [PubMed: 9207362] <br />                                                   36. Goluszko P, Moseley SL, Truong LD, Kaul A, Williford JR, Selvarangan R, Nowicki S, Nowicki <br />                                                       B. Development experimental model chronic pyelonephritis Escherichia coli O75:K5:H- <br />                                                       bearing Dr fimbriae: mutation dra region prevented tubulointerstitial nephritis. J Clin Invest. <br />                                                       1997; 99:1662&#226;&#8364;&#8220;1672. [PubMed: 9120010] <br />                                                   37. Wan X, Yokoyama Y, Shinohara A, Takahashi Y, Tamaya T. PTEN augments staurosporine- <br />                                                       induced apoptosis PTEN-null Ishikawa cells downregulating PI3K/Akt signaling pathway. <br />                                                       Cell Death Differ. 2002; 9:414&#226;&#8364;&#8220;420. [PubMed: 11965494] <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                                      Page 12 <br />  <br />  <br />                                                   38. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation regulation Akt/PKB by <br />                                                       rictor-mTOR complex. Science. 2005; 307:1098&#226;&#8364;&#8220;1101. [PubMed: 15718470] <br />                                                   39. Kawasaki K, Smith RS Jr, Hsieh CM, Sun J, Chao J, Liao JK. Activation the <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                       phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced <br />                                                       endothelial cell migration angiogenesis. Mol Cell Biol. 2003; 23:5726&#226;&#8364;&#8220;5737. [PubMed: <br />                                                       12897144] <br />                                                   40. Nowicki B, Fang L, Singhal J, Nowicki S, Yallampalli C. Lethal outcome uterine infection in <br />                                                       pregnant nonpregnant rats increased death rate inhibition nitric oxide. Am J <br />                                                       Reprod Immunol. 1997; 38:309&#226;&#8364;&#8220;312. [PubMed: 9352021] <br />                                                   41. Banadakoppa M, Liebenthal D, Nowak DE, Urvil P, Yallampalli U, Wilson GM, Kishor A, <br />                                                       Yallampalli C. Role transcription factor Sp1 RNA binding protein HuR the <br />                                                       downregulation Dr+ Escherichia coli receptor protein decay accelerating factor (DAF CD55) <br />                                                       nitric oxide. FEBS J. 2013; 280:840&#226;&#8364;&#8220;854. [PubMed: 23176121] <br />                                                   42. Beachey EH. Bacterial adherence: adhesin-receptor interactions mediating attachment of <br />                                                       bacteria mucosal surface. J Infect Dis. 1981; 143:325&#226;&#8364;&#8220;345. [PubMed: 7014727] <br />                                                   43. Nowicki B, Selvarangan R, Nowicki S. Family Escherichia coli Dr adhesins: decay-accelerating <br />                                                       factor receptor recognition invasiveness. J Infect Dis. 2001; 183(Suppl 1):S24&#226;&#8364;&#8220;S27. [PubMed: <br />                                                       11171008] <br />                                                   44. Guignot J, Peiffer I, Bernet-Camard MF, Lublin DM, Carnoy C, Moseley SL, Servin AL. <br />                                                       Recruitment CD55 CD66e brush border-associated glycosylphosphatidylinositol-anchored <br />                                                       proteins members Afa/Dr diffusely adhering family Escherichia coli infect the <br />                                                       human polarized intestinal Caco-2/TC7 cells. Infect Immun. 2000; 68:3554&#226;&#8364;&#8220;3563. [PubMed: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                       10816511] <br />                                                   45. Nowicki B, Labigne A, Moseley S, Hull R, Hull S, Moulds J. The Dr hemagglutinin, afimbrial <br />                                                       adhesins AFA-I AFA-III, F1845 fimbriae uropathogenic diarrhea-associated <br />                                                       Escherichia coli belong family hemagglutinins Dr receptor recognition. Infect Immun. <br />                                                       1990; 58:279&#226;&#8364;&#8220;281. [PubMed: 1967170] <br />                                                   46. Lalioui L, Jouve M, Gounon P, Le BC. Molecular cloning characterization afa-7 and <br />                                                       afa-8 gene clusters encoding afimbrial adhesins Escherichia coli strains associated diarrhea <br />                                                       septicemia calves. Infect Immun. 1999; 67:5048&#226;&#8364;&#8220;5059. [PubMed: 10496877] <br />                                                   47. Lalioui L, Le BC. afa-8 Gene cluster carried pathogenicity island inserted the <br />                                                       tRNA(Phe) human bovine pathogenic Escherichia coli isolates. Infect Immun. 2001; <br />                                                       69:937&#226;&#8364;&#8220;948. [PubMed: 11159989] <br />                                                   48. Nowicki B, Moulds J, Hull R, Hull S. A hemagglutinin uropathogenic Escherichia coli <br />                                                       recognizes Dr blood group antigen. Infect Immun. 1988; 56:1057&#226;&#8364;&#8220;1060. [PubMed: 2895740] <br />                                                   49. Berger CN, Billker O, Meyer TF, Servin AL, Kansau I. Differential recognition members the <br />                                                       carcinoembryonic antigen family Afa/Dr adhesins diffusely adhering Escherichia coli <br />                                                       (Afa/Dr DAEC). Mol Microbiol. 2004; 52:963&#226;&#8364;&#8220;983. [PubMed: 15130118] <br />                                                   50. Servin AL. Pathogenesis Afa/Dr diffusely adhering Escherichia coli. Clin Microbiol Rev. 2005; <br />                                                       18:264&#226;&#8364;&#8220;292. [PubMed: 15831825] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   51. Nowicki B, Truong L, Moulds J, Hull R. Presence Dr receptor normal human tissues and <br />                                                       possible role pathogenesis ascending urinary tract infection. Am J Pathol. 1988; <br />                                                       133:1&#226;&#8364;&#8220;4. [PubMed: 3052090] <br />                                                   52. O&apos;Brien DP, Israel DA, Krishna U, Romero-Gallo J, Nedrud J, Medof ME, Lin F, Redline R, <br />                                                       Lublin DM, Nowicki BJ, Franco AT, Ogden S, Williams AD, Polk DB, Peek RM Jr. The role of <br />                                                       decay-accelerating factor receptor Helicobacter pylori mediator gastric <br />                                                       inflammation. J Biol Chem. 2006; 281:13317&#226;&#8364;&#8220;13323. [PubMed: 16543227] <br />                                                   53. O&apos;Brien DP, Romero-Gallo J, Schneider BG, Chaturvedi R, Delgado A, Harris EJ, Krishna U, <br />                                                       Ogden SR, Israel DA, Wilson KT, Peek RM Jr. Regulation Helicobacter pylori cellular <br />                                                       receptor decay-accelerating factor. J Biol Chem. 2008; 283:23922&#226;&#8364;&#8220;23930. [PubMed: 18579524] <br />                                                   54. Bergelson JM, Chan M, Solomon KR, St John NF, Lin H, Finberg RW. Decay-accelerating factor <br />                                                       (CD55), glycosylphosphatidylinositol-anchored complement regulatory protein, receptor for <br />                                                       echoviruses. Proc Natl Acad Sci U S A. 1994; 91:6245&#226;&#8364;&#8220;6248. [PubMed: 7517044] <br />  <br />  <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                                    Page 13 <br />  <br />  <br />                                                   55. Bergelson JM, Mohanty JG, Crowell RL, St John NF, Lublin DM, Finberg RW. Coxsackievirus <br />                                                       B3 adapted growth RD cells binds decay-accelerating factor (CD55). J Virol. 1995; <br />                                                       69:1903&#226;&#8364;&#8220;1906. [PubMed: 7531780] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   56. Karnauchow TM, Tolson DL, Harrison BA, Altman E, Lublin DM, Dimock K. The HeLa cell <br />                                                       receptor enterovirus 70 decay-accelerating factor (CD55). J Virol. 1996; 70:5143&#226;&#8364;&#8220;5152. <br />                                                       [PubMed: 8764022] <br />                                                   57. Krachler AM, Woolery AR, Orth K. Manipulation kinase signaling bacterial pathogens. J <br />                                                       Cell Biol. 2011; 195:1083&#226;&#8364;&#8220;1092. [PubMed: 22123833] <br />                                                   58. Black DS, Bliska JB. Identification p130Cas substrate Yersinia YopH (Yop51), a <br />                                                       bacterial protein tyrosine phosphatase translocates mammalian cells targets focal <br />                                                       adhesions. EMBO J. 1997; 16:2730&#226;&#8364;&#8220;2744. [PubMed: 9184219] <br />                                                   59. Peiffer I, Servin AL, Bernet-Camard MF. Piracy decay-accelerating factor (CD55) signal <br />                                                       transduction diffusely adhering strain Escherichia coli C1845 promotes cytoskeletal F-actin <br />                                                       rearrangements cultured human intestinal INT407 cells. Infect Immun. 1998; 66:4036&#226;&#8364;&#8220;4042. <br />                                                       [PubMed: 9712744] <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                          Page 14 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Figure 1. <br />                                                   The association constitutive activity PI3K/Akt pathway adhesion Dr+ E. <br />                                                   coli epithelial cells. The expression PI3K/Akt pathway proteins HeLa Ishikawa <br />                                                   cell grown monolayers 24 hours examined western blot. The E. coli K-12 <br />                                                   strain carrying plasmid pBJN406, encoding production Dr fimbriae allowed <br />                                                   bind HeLa Ishikawa cells hours number bacteria adhered <br />                                                   individual cells examined gram staining. (a) Western blot PTEN, total PDK1 <br />                                                   total Akt proteins HeLa Ishikawa cells. (b) Western blot pPDK1 protein in <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                           Page 15 <br />  <br />  <br />                                                   HeLa Ishikawa cells. (c) Densitometric analysis pPDK1 protein levels. * p &lt; 0.0001 <br />                                                   versus HeLa. (d) Western blot activated forms Akt, pAkt(ser473) pAkt(Thr308). <br />                                                   (e) Western blot DAF. (f) Gram staining visualize E. coli K-12 strain carrying plasmid <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   pBJN406 adhered HeLa Ishikawa cells. Data representative images expressed <br />                                                   mean values &#194;&#177; SEM group separate experiments. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                           Page 16 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Figure 2. <br />                                                   Up-regulation DAF pharmacological inhibitor PI3K/Akt pathway. The monolayer <br />                                                   Ishikawa cells treated LY 294002 (50 &#194;&#181;M) dissolved DMSO DMSO alone <br />                                                   (control) 24 hours. (a) Western blot total Akt activated forms, pAkt(ser473) <br />                                                   pAkt(Thr308). (b) Density analysis pAkt(ser473) western blot expressed ratio <br />                                                   total Akt pAkt(ser473). * p &lt; 0.0001 versus control. (c) Density analysis of <br />                                                   pAkt(Thr308) western blot expressed ratio total Akt pAkt(Thr308). * p &lt; <br />                                                   0.01 versus control. (d) Fold increase expression DAF mRNA assessed real <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                          Page 17 <br />  <br />  <br />                                                   time qPCR treating Ishikawa cells LY294002. * p &lt; 0.001 versus control. <br />                                                   (e) Western blot DAF protein (f) Density analysis DAF western blot expressed fold <br />                                                   increase expression treating Ishikawa cells LY294002. p &lt; 0.03 versus <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   control. Data representative images expressed mean values &#194;&#177; SEM group <br />                                                   separate experiments. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                   Page 18 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                   Page 19 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                           Page 20 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Figure 3. <br />                                                   Up-regulation DAF increase Dr+ E. coli adhesion expression PTEN in <br />                                                   Ishikawa cells. Ishikawa cells transiently transfected plasmid encoding functional <br />                                                   PTEN gene. For control, cells treated equivalent transfection regent <br />                                                   lipofectamine 2000. After 24 hours transfection, cells lysed western blot <br />                                                   real time qPCR E coli. K-12 strain carrying plasmid pBJN406, encoding the <br />                                                   production Dr fimbriae allowed bind cells 3 hours. The number of <br />                                                   bacteria adhered cell counted gram staining. Similarly, Ishikawa cells <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                           Page 21 <br />  <br />  <br />                                                   sparsely grown 16-well lab-Tek chamber slides transfected mentioned above, <br />                                                   fixed using formalin proximity ligation assay performed. (a) Western blot PTEN <br />                                                   expression. (b) Density analysis western blot indicating fold increase PTEN <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   protein expression. * p &lt; 0.05 versus control. (c) Western blot total PDK1, total Akt and <br />                                                   activated forms, pPDK1, pAkt(ser473) pAkt(Thr308). (d) Western blot density <br />                                                   analysis pPDK1 protein levels expressed ratio pPDK1 total PDK1. * p &lt; <br />                                                   0.05 versus control. (e) Western blot density analysis pAkt(ser473) expressed ratio <br />                                                   pAkt(ser473) total Akt. * p &lt; 0.05 versus control. (f) Western blot density <br />                                                   analysis pAkt(Thr308) expressed ratio pAkt(Thr308) total Akt. * p &lt; <br />                                                   0.001 versus control. (g) Fold increase DAF mRNA assessed real time qPCR. * p &lt; <br />                                                   0.0001 versus control. (h) Western blot DAF protein expression. (i) Density analysis of <br />                                                   western blot indicating fold increase DAF protein expression. * p &lt; 0.001 versus <br />                                                   control. (j) PLA assay expression DAF protein surface Ishikawa cells. <br />                                                   (k) The DAF protein levels surface Ishikawa cells assessed PLA assay, <br />                                                   expressed number signals nucleus. * p &lt; 0.01 versus control. (l) The adherence of <br />                                                   E. coli K-12 strain carrying plasmid pBJN406 Ishikawa cells revealed gram <br />                                                   staining. (m) The average number bacteria adhered cell. * p &lt; 0.01 versus control. <br />                                                   Data representative images expressed mean values &#194;&#177; SEM group three <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   separate experiments. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                   Page 22 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                   Page 23 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                            Page 24 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   Figure 4. <br />                                                   Down-regulation PTEN using PTEN-specific siRNA down-regulated DAF expression <br />                                                   decreased Dr+ E. coli adhesion HeLa cells. The HeLa cells transiently <br />                                                   transfected PTEN-specific siRNA. For control, cells treated scrambled <br />                                                   siRNA. After 24 hours transfection, cells lysed western blot real time <br />                                                   qPCR E coli. K-12 strain carrying plasmid pBJN406, encoding production Dr <br />                                                   fimbriae allowed bind cells 3 hours. The number bacteria adhered per <br />                                                   cell counted gram staining. Similarly, HeLa cells sparsely grown 16-well <br />  <br />  <br />                                                 Exp Biol Med (Maywood). Author manuscript; available PMC 2014 November 01. <br />                             Banadakoppa et al.                                                                                           Page 25 <br />  <br />  <br />                                                   lab-Tek chamber slides transfected mentioned above, fixed using formalin and <br />                                                   proximity ligation assay performed. (a) Western blot PTEN expression. (b) Density <br />                                                   analysis western blot indicating fold decrease PTEN protein expression. * p &lt; <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                   0.01 versus control. (c) Western blot total PDK1, total Akt activated forms, <br />                                                   pPDK1, pAkt(ser473) pAkt(Thr308). (d) Western blot density analysis pPDK1 <br />                                                   protein levels expressed ratio pPDK1 total PDK1. * p &lt; 0.05 versus control. <br />                                                   (e) Western blot density analysis pAkt(ser473) expressed ratio pAkt(ser473) <br />                                                   total Akt. * p &lt; 0.001 versus control. (f) Western blot density analysis pAkt(Thr308) <br />                                                   expressed ratio pAkt(Thr308) total Akt. * p &lt; 0.001 versus control. (g) Fold <br />                                                   decrease DAF mRNA assessed real time qPCR. * p &lt; 0.01 versus control. (h) <br />                                                   Western blot DAF protein expression. (i) Density analysis western blot indicating the <br />                                                   fold decrease DAF protein expression. * p &lt; 0.05 versus control. (j) PLA assay the <br />                                                   expression DAF protein surface HeLa cells. (k) The DAF protein levels the <br />                                                   surface HeLa cells assessed PLA assay, expressed number signals nucleus. <br />                                                   * p &lt; 0.01 versus control. (l) The adherence E. coli K-12 strain carrying plasmid <br />                                                   pBJN406 HeLa cells revealed gram staining. (m) The average number of <br />                                                   bacteria adhered cell. * p &lt; 0.05 versus control. Data representative images or <br />                                                   expressed mean v <br /> </body></html>